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The alarming rate of antibiotic resistance in human p thogens causes a pressing need for 
improved diagnostic technologies aimed at rapid detection and point of care testing to 
support quick decision making on antibiotic therapy nd patient management. Here, we 
report the successful development of an electrochemical biosensor to detect blaNDM, the 
gene encoding for the emerging New Delhi metallo-beta-lactamase, using label-free 
electrochemical impedance spectroscopy (EIS). The presence of this gene is of critical 
concern as organisms harboring blaNDM tend to be multi resistant leaving very few 
treatment options. For the EIS assay we used a blaNDM specific PNA probe which was 
designed applying a new approach of combining in silico probe design and fluorescence-
based DNA microarray validation with electrochemical testing on gold screen-printed 
electrodes. The assay was successfully demonstrated for synthetic targets (LOD = 10 
nM), PCR products (LOD = 100 pM) and the direct, amplification free detection from the 
blaNDM harboring plasmid. The biosensor’s specificity, preanalytical requirements and 
performance under ambient conditions were demonstrated nd successfully proved its 




In the EU over 25,000 patients die annually from infection due to antibiotic resistance.1 
While until recently resistance in gram positive bacteria such as Methicillin-resistant 
Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE) have 
been the primary focus of clinicians, the increasing prevalence of multidrug resistant 
gram negative pathogens in combination with the lack of antimicrobials in development 
become the biggest and most pressing concern in human healthcare.2-4 Beta-lactam 
antibiotics conventionally used to target such infections at present make up more than 
half of antibiotics used in the world and these multi-resistant gram negative strains pose 
a severe public health threat.5 
 
The blaNDM gene was first isolated from a Swedish patient previously hospitalised in India 
in 2008, and has disseminated to broad geographical loc tions6, predominantly linked to 
treatment in the Indian region, though also through independent routes.7 The presence of 
the gene is of pivotal concern as organisms harboring blaNDM tend to be multi resistant 
and some are only sensitive in vitro to agents of uncertain efficacy such as tigecycline 
and colistin, leaving few treatment options.2 Originally identified in E. coli and Klebsiella 
strains, the gene is now found in many Enterobacteriaceae responsible for a spectrum of 
infections such as sepsis and urosepsis. The blaNDM- gene is carried on plasmids of various 
sizes, easily transferred laterally between gram negative genera. As a result, prompt 
identification of NDM strains is of paramount importance to prevent transmission and 
dissemination of resistant strains. 
 
Many diagnostic methods currently in use for detection of extended-spectrum beta-
lactamase (ESBL) and Carbapenemase producing bacteria ar  culture based, with a time-
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to-result (TTR) incompatible with a rapid treatment decision (e.g. ChromID ESBL, Etest 
ESBL, Vitek (bioMerieux) etc.).8-11 Some molecular diagnostic approaches for detection 
of beta-lactam resistance in gram negative bacteria al eady exist in the market such 
Check-MDR (Checkpoints), Evigene (AdvanDx), Hyplex SuperBug ID (Amplex) etc. 
but are not suited for true point of care detection as they are based on sophisticated optical 
detection systems and require demanding sample preparation and preanalytics.12-14 In 
contrast, electrochemical biosensors offer exciting possibilities for decentralized clinical 
applications due to their specificity, speed, portability, and low cost.  
 
Electrochemical impedance spectroscopy (EIS) is a technique which can be applied to 
gather information on biorecognition events on functionalised electrode surfaces.15-19 
Detection of DNA hybridisation with EIS is a growing field of study and has been covered 
in recent review articles.15,20 Conventionally, nucleic acid probes are immobilised on the 
electrode surfaces as part of an alkane thiol mixed self-assembled monolayer (SAM).21,22 
Upon EIS measurements in the presence of a redox mediator such as potassium ferri-
ferrocyanide negative charges accumulate on the electrode surface during target 
hybridisation and an increase in resistance to charge transfer is detected. This may result 
from the combined effects of increases due to repulsion of anionic redox mediators at the 
electrode surface and blocking of SAM pinholes by bound target slowing electron 
transfer.23 The method lends itself well to multiplex detection within an electrode array 
whereby multiple markers of infection and resistance may be interrogated in parallel, as 
a feasible extension of the dual working electrode setup employed herein.16 Using EIS, 
we previously demonstrated detection of PCR products derived from the gene target mecA 




Here, we report the development of an EIS assay for the direct, label-free detection of the 
multidrug resistance causing blaNDM gene. A blaNDM specific probe was designed in-silico 
and selected from 36 candidate probes using fluorescence-based microarrays. With this 
probe immobilized on gold screen-printed electrodes w  developed a label-free EIS assay 
for the detection of blaNDM PCR products and also for direct, label- and amplification-free 
detection of blaNDM plasmid DNA. 
 
Materials and Methods 
Reagents 
DNA oligonucleotides were purchased from Metabion (Martinsried, Germany). PNA 
oligonucleotides were ordered via Cambridge Research Biochemicals (Cleveland, UK) 
from Panagene (Daejeon, South Korea). PCR kit and Qiaspin Miniprep kits were 
purchased from Qiagen (Crawley, UK). Potassium ferricyanide, potassium ferrocyanide, 
phosphate buffered saline, monosodium phosphate, disodium phosphate and dimethyl 
sulfoxide (DMSO) were purchased from Sigma Aldrich (Poole, UK). Lambda 
exonuclease was sourced from EURx (Gdansk, Poland). Deionised water was used 
throughout the study (>18 MΩ cm). DNase RQ1 was obtained from Promega (Mannheim, 
Germany). The clinical isolate used for all investiga ons was a NDM-1 producing 
Citrobacter freundii strain isolated at the Edinburgh Royal Infirmary. 
 
In-silico NDM-1 probe design 
blaNDM specific probes of 20 nt in length were designed in silico with an online tool named 
UPS Unique Probe Selector (http://array.iis.sinica.edu.tw/ups/). The UPS algorithm 
considers “GC content, the secondary structure, melting temperature (Tm), the stability 
of the probe-target duplex estimated by the thermodynamic model, sequence complexity, 
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similarity of probes to non-target sequences, and other empirical parameters used in the 
laboratory” when selecting probes. 
 
The option to select probes at a ‘pangenomic level’ was selected and the 826bp laNDM-1 
sequence (accession no. FN396876.1) was entered in FASTA format. A salt concentration 
of 0.33M was specified and subsequently 10 probes, 20 nucleotides in length were 
generated. The candidate set of probes were further scrutinized as follows and as a result 
of analysis seven of 10 probes were selected for further investigation. Using 
OligoAnalyzer 3.1 (http://eu.idtdna.com/analyzer/applications/oligoanalyzer/), the %GC 
content, melting temperatures (Tm) and the free energy (∆G) values of possible secondary 
structures such as self-dimer and hairpin structures w re all considered. The sodium ion 
concentration was adjusted from 50 mM to 330 mM but default settings remained 
otherwise. The results were used to refine the probe selection upon recommendation. All 
probe candidates were subjected to a further specificity test using BLASTN 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) and Probecheck (http://131.130.66.200/cgi-
bin/probecheck/content.pl?id=home).24 The candidate sequences were entered in FASTA 
format to both servers and checked against the nr/nt database within BLASTN and both 
the 16S/18S rRNA and the 23S/28S rRNA databases within Probecheck. Default settings 
were used in both cases. The complete probe set chosen f r further experiments consisted 
of two previously identified primers (probes numbered 29-32 25 and 32-36 26 ) and seven 
UPS generated probe sequences (Table S-2).  
 
The investigation took into account the difference b tween sense and anti-sense 
hybridization as well as the potential variability that may arise from immobilizing the 
probes at either the 5’ or the 3’ end of the oligonucleotide probe. In this regard, probes 
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were ordered with amino modification at 5’ or 3’ of the sequence for immobilisation of 
both orientations. Sense (the strand corresponding to mRNA sequence) and anti-sense 
(the strand complementary to the mRNA sequence) sequences were also investigated as 
variability in hybridization efficiency also occurs in this respect. This doubled the size of 
the probe set of nine deduced from the selection prcess to 18. Each of the 18 probes, 
both sense and anti-sense, was designed with a 12-thymine spacer and amino-
modification at either the 5’ or 3’ end. This concluded the blaNDM-1 specific probe 
selection process with a total of 36 probes deduced from the initial pool of nine probes. 
Sequences of each probe are shown within supplementary materials (Table S-2). 
 
DNA extraction and PCR 
Plasmid DNA was extracted from an overnight Luria-Bertani Broth culture of an NDM-
1 producing Citrobacter freundii clinical isolate using Qiaspin Miniprep Kit (Qiagen 
Crawley, UK). For PCR amplification 5µL Citrobacter freundii NDM-1 plasmid DNA 
was mixed with 4 µM blaNDM-1 specific primers (sequence shown in Supporting 
Information), 0.1 mM dNTPs, 1x Taq buffer, 1x Q solution, 1.0 mM MgCl2 and 0.1 U 
HotstarTaq polymerase (Qiagen, Hilden, Germany) in a final volume of 25 µL. The 
blaNDM-1 specific forward primer was 5’phosphate modified for Lambda exonuclease 
treatment to produce single-stranded products. Where fluorescent PCR products were 
required for microarray dNTPs were substituted with 0.1 mM dATP, dGTP and dTTP 
were added, in combination with 0.6 mM dCTP and 0.4 mM dCTP-Cy3 (GE healthcare, 
Buckinghamshire, UK). PCR products used in microarray work, TEM, SHV, KPC and 
16S PCR were produced using the same reagent concentratio s and conditions and 
primers detailed in supporting information. The amplification was performed in a Techne 
TC-512 thermal cycler (Bibby Scientific Limited, Stone, UK) using the following 
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protocol: 95°C for 15 min; 30 cycles at 95°C for 1 min, 50° C for 1 min and 72°C for 1 
min; followed by a final elongation at 72°C for 10 min. Upon completion of the reaction 
amplicon was pooled and Lambda exonuclease treated.  
 
DNA enzymatic treatments  
To perform exonuclease treatment 200 ng PCR product was incubated with 15 U Lambda 
exonuclease (EURx, Gdansk, Poland) in 1x exonuclease buffer for 25 min at 37°C. In 
optimisation experiments incubation times of 5, 15 and 25 min were applied at 37°C. The 
enzyme was then inactivated at 95 °C for 5 min followed by cooling on ice. DNase treated 
plasmid was prepared by incubating the DNA with 0.8 mU DNase I (Promega, 
Mannheim, Germany) per ng plasmid in 1x DNase buffer or 1.5 min at room 
temperature. By adding 3mM ethylene glycol tetraacetic acid (EGTA) and incubating at 
65°C for 10 min, the fragmentation reaction was stopped. For plasmid linearization, S1 
nuclease 100U per µg of DNA was incubated for 20 min at 37°C, in the presence of 1X 
nuclease buffer. The reaction was stopped with 16 mM EDTA and heating at 70°C as 
recommended by the manufacturer.  
 
DNA Electrophoresis  
Following enzymatic treatments, DNA molecular weight was confirmed by standard 
electrophoresis or capillary electrophoresis. Capill ry electrophoresis was performed 
using the Bioanalyzer 2100 (Agilent, UK) according to the manufacturer’s instructions. 
In order to fractionate high molecular weight plasmid DNA, samples were 
electrophoresed on 2% SybrSafe (Life Technologies, UK) 1% Agarose (Sigma-Aldrich, 
UK) gel at 20 V for 8 hrs alongside GeneRuler 50 bp and high molecular weight ladders 




DNA microarray fabrication 
Amino-modified oligonucleotides were spotted in 1x Schott Nexterion spot buffer (20 
µM) in replicates of three within each array on Schott Nexterion Slides E (epoxy silane 
modified surface; Schott, Jena, Germany) with four 200µm (diameter) split pins and a 
MicroGrid II (BioRobotics, Cambridge, UK) at 40-50% relative humidity at room 
temperature. Epoxysilane slides were immediately immobilized at a relative humidity of 
75% at room temperature for 1 h followed by storage overnight at room temperature under 
dry conditions. This generated spots with a diameter of approximately 200 µm. Each 
oligonucleotide was equipped with a 12-thymidine spacer and an amino modification at 
the 5’ end. The slides were then washed with 0.1% TritonX-100 solution under constant 
mixing for 5 min at RT, with 1 mM HCl solution for 4 min, with 100 mM KCl solution 
for 10 min, and with deionized water for 1 min. The slides were blocked with 50 mM 
ethanolamine + 0.1% sodium dodecyl sulfate (SDS) in 0.1 M Tris buffer (pH 9) for 15 
min at 50 °C. After blocking the slides were washed in deionized water for 1 min and 
then dried by centrifugation (2 min at 800 g).  
 
Microarray hybridization and data acquisition 
Hybridization was done using Agilent 8 gasket slides and hybridization chambers 
(Agilent Technologies, Stockport, UK). Fifty microliter hybridization solution, consisting 
of 100 nM hybridization control plus blaNDM-1 PCR product, 2x SSC (300 mM NaCl + 30 
mM Na-citrate), were added to each of the gaskets. The printed slide which had been 
washed and blocked was placed array facing down on top of the hybridization solution. 
The sandwich slides were then sealed using a hybridizat on chamber and rotated in a pre-
heated oven at 55ºC for 2 h. Epoxysilane slides were ashed with 2x SSC + 0.1 % SDS 
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for 10 min, 2x SSC for 10 min, 0.2x SSC for 10 min. Each slide was then dipped in H20 
for a few seconds and dried by centrifugation for 2 min at 800 g. 
Fluorescence images were generated with a Tecan LS Reloaded fluorescence scanner 
(Tecan, Maennedorf, Switzerland) with excitation at 532 nm and emission at 575 nm. 
Quantification of fluorescence signal intensities was performed with the Quantarray 
software (Perkin Elmer, Waltham, MA) using the histogram quantification method. For 
further analysis, the mean signal intensity minus loca  background intensity was 
processed with Excel (Microsoft Corp., Redmond, USA) and the mean and standard 
deviation of all replicates were calculated. 
 
Electrode Preparation 
Screen printed dual gold working electrode (1.75 mmX 4 mm, low temperature curing 
gold ink) sensors with an integrated Ag/AgCl referenc  electrode (Dropsens, Oviedo, 
Spain) were cleaned using cyclic voltammetry in 100 mM aqueous sulphuric acid and 
functionalised with 1.5 µM thiol-modified PNA solution + 30 µM mercaptohexanol + 5 
mM Tris(2-carboxyethyl)phosphine in 50 % (v/v) as described in previous publication 
from this laboratory.23  
 
EIS Measurement 
Following functionalization, EIS measurements were performed on screen printed 
sensors connected to an Autolab PGSTAT12 potentiosta  (Metrohm Autolab, Herisau, 
Switzerland ) controlled by Nova software at open circuit potential at an amplitude of 10 
mV rms at 15 frequencies in the range 100 000 Hz – 0.1 Hz.23 Hybridization and 
measurement were performed in 0.1 mM K4[Fe(CN)6] + 0.1 mM K3[Fe(CN)6] + 10 mM 
phosphate buffer + 20 mM NaCl, pH 7. In the case of DNase treated plasmid DNA, 
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sample was heated to 95°C for 5 min, and transferred to ice for 2 min prior to 





Results and Discussion 
EIS assay design 
In order to develop a sensitive and specific blaNDM assay, parameters pertaining to assay 
design, measurement conditions and target state wer considered. Implementation of EIS 
to achieve sensitive detection of nucleic acids has been explored in many assay formats.27-
30 Here, uncharged PNA probes were used in place of polyanionic DNA which allow a 
low background signal to be achieved resulting in improved resolution upon binding of 
charged DNA target as described previously.31-33  
 
Probe density within an alkane-thiol monolayer of 5% mole fraction was employed for 
optimal sensitivity, in keeping with unpublished data from our laboratory and literature 
under similar conditions.34 When dealing with long DNA targets a trade-off exists 
between the theoretical EIS signal enhancement and the accessibility of the target 
sequence. Enhanced EIS signal transduction is expected resulting from the abundant 
negative charges of the target hybridised at the electrode surface causing a higher degree 
of repulsion of anionic redox mediators. However, a large DNA target may result in a 
lower accessibility of the 20 nucleotides (nt) complementary to the immobilised probe. 
In this regard, achieving an optimal probe density and target length are key components 
of sensitive detection.  
 
The use of low ionic strength solution during EIS measurement allows greater sensitivity 
to be achieved resulting from the increase in the electrostatic barrier for the redox 
mediator to reach the electrode surface upon target hybridization. While the on-line assay 
format demonstrated herein implies that both DNA-PNA hybridization and measurement 
take place in one solution, optimal ionic strength reported by Keighley et al of 10 mM 
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electrolyte was successfully implemented.34 Within each dual working electrode EIS 
assay, a PNA-free working electrode was included for SAM quality control and 
background normalization of non-specific absorption of molecules on the electrode 
surface which contributed to specificity of the assay. 
 
In silico design and microarray validation of blaNDM-1 probe sequences  
To facilitate EIS investigations for development of a blaNDM biosensor, it was necessary 
to develop probe sequences which could specifically nd sensitively detect blaNDM 
sequences. This was achieved by in silico probe design and validation on glass DNA 
microarrays with fluorescently labelled blaNDM PCR products. blaNDM specific probes of 
20 nt in length were designed in silico with an online tool named UPS Unique Probe 
Selector, the merits of which are reviewed by Chen et al.35 Since the hybridisation 
efficiency of long PCR products with probes immobilised on solid supports is influenced 
by probe orientation and relative probe/target position both 3' and 5' immobilised sense 
and antisense probes were tested with regard to their affinity for the blaNDM PCR 
product.36,37 Probes were contact printed on glass epoxy coated slides immobilised via a 
12-thymine spacer and terminal amino-modification. The hybridization of fluorescence-
labelled PCR products which were generated using published blaNDM specific primers 
resulted in the highest fluorescence intensity for probe 7, which was consequently 
selected for the further EIS assay development (see Figure 1). Despite being selected by 
in silico analysis, many probe sequences proved unsuitable for hybridization of blaNDM 
PCR products. These observations showed that experimental validation of in silico 
designed probes using DNA microarrays is essential for identification of probes which 
bind efficiently to long DNA targets of interest when immobilised on a solid support. The 
use of fluorescence-based DNA microarrays for pre-sel ction of in-silico designed probes 
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enabled the test of a large number of probes in parallel which could not have been done 
on the electrochemical platform in the same time frame. This new approach of combining 
fluorescence-based DNA microarrays with electrochemical detection platforms for assay 
development has the potential to significantly enhance the assay performance of nucleic 
acid based, electrochemical in-vitro diagnostic tests. 
 
The probes were also tested for their cross reactivity towards other relevant antibiotic 
resistance gene specific PCR products, including gees ncoding for the beta-lactamases 
TEM, SHV and Klebsiella pneumoniae carbapenemase (KPC), and a P. aeruginosa 16S 
rDNA PCR product.38-41 As can be seen in Figure S-3, there was virtually no cross-
hybridization of any of the tested probes to P. aeruginosa 16S rDNA PCR product. 
Similar results were obtained with blaTEM, blaSHV and blaKPC PCR products (data not 
shown). A thiol-terminated PNA probe of equivalent sequence to probe 7 was obtained 
for EIS biosensor development. PNA probe P7 was design d to bind the blaNDM PCR 
product target with a short (32 nt) 3’ and long (571 nt) 5’ overhang. The long overhang 
was expected to be facing towards the bulk solution, which suits EIS application in terms 
of accessibility and signal transduction. Alignment of published sequences of all six 
current blaNDM variants (GenBank accession numbers JF826285.1, JF703135.1, 
JQ734687.1, JQ348841.1, JN104597.1, JQ235754.1) using alignment software 
(CodonCode Aligner, CodonCode Corporation, USA) showed that this probe sequence 
targeted a conserved region within the blaNDM gene.  
EIS detection of synthetic DNA target 
The blaNDM specific PNA probe 7 was first tested with a short artificial target directly 
complementary to the probe sequence. The applied EIS setup enabled the direct, label-
free detection of target hybridization to the immobilized probe. EIS measurements prior 
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to and after target addition allowed the hybridization to be monitored over the course of 
ten subsequent EIS spectra, each plotted as Nyquist Plots for capture of charge transfer 
resistance values (Rct). As an example, the Rct value increased by more than 1600 % 
(dRcT = 17) after 50 min incubation with 500 nM short, synthetic target. Figure 2 shows 
the standard curve which was established based on the signal increase ratio (dRct) after 
60 min (52 min after target addition, respectively the tenth consecutive EIS measurement 
after target addition). The limit of detection (LOD) of hybridization of a synthetic 
oligonucleotide to immobilised PNA probes defined as the buffer negative control signal 
plus three times the standard deviation was determined to be 10 nM (10x10-9M).  
EIS detection of PCR product 
PCR products were generated using plasmid DNA isolated from an NDM-1 producing 
Citrobacter freundii strain isolated at the Edinburgh Royal Infirmary and published 
primers. Initially, investigations into hybridization of double stranded PCR products on 
PNA probe 7 functionalised electrode chips were carried out. However, the Rct change 
yielded upon hybridization of 10 nM blaNDM-1 PCR product (620 bp, dsDNA) was in the 
range of non-specific absorption observed on the PNA-negative control electrode and 
upon hybridization of non-complementary DNA (see Figure 3). We were expecting 
higher signals caused by an invasion of PNA into the dsDNA helix displacing the 
complementary DNA strand or forming a stable triplex structures.42 On the other hand,  
the ability of immobilised PNA to infiltrate the dsDNA target may be hindered by the 
restricted accessibility of the immobilized PNA probe, the length of the dsDNA target, 
and the ionic strength of the solution.43 Consequently, a protocol for generation of ssDNA 
target was applied to improve target accessibility. Lambda exonuclease, which degrades 
one strand of double-stranded DNA in 5’-3’ direction when a phosphate is present at the 
5’ position was employed for this purpose.44 The use of Lambda exonuclease to enhance 
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fluorescence-based DNA microarray and EIS assay performance has been reported 
previously by our group.23,36 Upon digestion, PCR products were analyzed by capillary 
electrophoresis. The ssDNA state of digested product was identified by altered migration 
in the gel (above the upper marker at >1500bp), since ssDNA tends to fold into secondary 
structures (Figure S-1). The hybridization of 10 nMof 620 bp long ssDNA blaNDM PCR 
product produced a specific, significant Rct signal i crease. Figure 3 shows the signal 
change over time caused by target binding to the probe under ambient conditions without 
mixing of the solution. Optimisation of enzyme digestion time over a range of 5-25 min 
allowed a further enhancement of this detection, with a 20% increase in sensitivity when 
25 min incubation time was applied (see Figure 3). This optimized Lambda exonuclease 
treatment protocol applied to 10 nM blaNDM PCR product generated a Rct value increase 
of 170% (dRct 2.7) after 28 min incubation. Figure 3 shows also that there is already a 
significant signal change within the first 10 min after target addition, however 
measurement was continued for 45 min. Under the laboratory set up used time to result 
across a linear range has not been optimized and there is scope for improvement in this 
regard in terms of system miniaturization and use of an enclosed flow cell or microfluidic 
apparatus.45  
 
The 620 bp blaNDM ssPCR product was tested over a concentration range from  0.1 to 50 
x 10-9M and an EIS standard curve was constructed using Rct data derived from Nyquist 
plots of baseline EIS spectra (before target addition) and after ten consecutive EIS 
measurements following sample addition which corresponds to a hybridization time of 
52 min (Figure 4). A LOD of 100 pM (0.1x10-9M; 0.05 ng/µL) was achieved. This very 
sensitive detection of long single-stranded PCR products and a 100-time lower LOD 
compared to the detection of a short complementary get was attributed to the 
17 
 
enhancement of EIS signal transduction resulting from the large number of negative 
charges at the electrode surface repelling anionic redox mediators. These results correlate 
well with data previously received by us for the EIS based mecA detection, where we 
observed a LOD of 10 nM (10x10-9M)  for an artificial target and even an 1,000-times 
lower 10 pM (10x10-12M) LOD for mecA PCR products.23  
NDM PCR products of 100 pM can be generated from 103 gene copies/mL as determined 
by colony counting. This LOD of 103 gene copies/mL is similar to the LOD described by 
a commercial molecular assay for ESBL and carbapenem resistances in Gram negative 
bacteria. The hyplex SuperBug ID test (Amplex Biosystems, Gars, Germany; 
http://www.hyplex.de/index.php?id=126&L=2)) which is based on PCR amplification 
and reverse hybridisation can detect NDM-1 genes together with other resistance genes 
in 2.5 – 4 h with a LOD of 9.3 x 103 gene copies/mL. While growth based methods such 
as chromID ESBL have lower limits of detection46 but the drawbacks of a much longer 
time to result and in vitro growth conditions are limiting.  
 
The specificity of direct EIS detection of ssPCR products under ambient conditions was 
investigated by comparison of blaNDM PCR product caused EIS response to 550 bp mecA 
ssPCR product23 on PNA probe 7 functionalised electrodes (all Lambda exonuclease 
treated). MecA PCR product was generated using published primers.47 Initial experiments 
performed in the absence of formamide yielded poor discrimination, with the non-
complementary DNA (mecA) causing Rct increases higher than for the complementary 
target (blaNDM), as shown in Figure 5. This low specificity was not unexpected 
considering the fact that the hybridization was performed under highly non-stringent 
conditions working at room temperature without mixing of the sample solution. However, 
as these conditions were desirable for a potential app ication of the blaNDM assay at the 
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point of care we investigated alternative ways to enhance the stringency. Here, the 
incorporation of 50% formamide during hybridization (still at room temperature) resulted 
in a 66% enhanced discrimination between the specific hybridization of the blaNDM  
ssDNA and the non-specific binding of the m cA ssDNA to PNA probe 7 as seen in Figure 
5.  
 
Amplification-free EIS detection of blaNDM plasmid DNA.  
Sample preparation has become a bottleneck for molecular diagnostics and a shift toward 
simpler pre-analytics would be advantageous in terms of rapid point of care diagnosis to 
aid informed treatment decisions. An amplification-free detection of nucleic acid targets 
avoiding PCR and thermal cycling requirements would significantly reduce the time-to-
result and the instrumental requirements of the test. Consequently, we investigated the 
direct detection of the target gene containing plasmid. The blaNDM-1 gene of the 
Citrobacter freundii clinical isolate detected in this study was encoded on an 
approximately 3.5 kb plasmid. The size of the plasmid was determined by S1 nuclease 
treatment and gel electrophoresis (see Figure S-2).48 
 
When using long DNA targets an enhancement in EIS signal transduction was expected, 
however, the large target size may result in a lower accessibility of the target sequence. 
Initial attempts to detect the intact plasmid and S1 treated linearized plasmids failed (data 
not shown). This may be attributed to the above mentioned reduced accessibility of this 
large target sequence. In addition, a plasmid targe may also contain some supercoiled 
regions if the plasmid is not completely linearized or a level of re-hybridisation may take 
place after a preanalytical denaturation step of the sample. Therefore, the effect of DNase 
treatment on detection of hybridisation was investigated. DNase treatment is routinely 
19 
 
used in hybridisation assays to improve accessibility of target sequences to probes. 
Success of DNase treatment in EIS depends on generating a target of a length with which 
the balance between accessibility and signal enhancement is optimum. The incubation of 
the plasmid DNA for 1.5 min with 0.8 U/ng DNase resulted in 25-50 bp long fragments, 
as can be seen in Figure S-2. These DNase treated plasmid samples could be detected 
directly by EIS at ambient conditions at the low nanomolar range (Figure 6). Data 
represented in Figure 6 show the specific signal increase normalised to Rct change on a 
negative control PNA functionalised electrode (sequence detailed in Table S-1). This is 
to the best of our knowledge the first example of direct, electrochemical plasmid DNA 
detection in an amplification- and label-free manner.  
 
Conclusion 
Rapid detection of blaNDM producing strains is of paramount importance to prevent 
transmission and dissemination of resistant strains. Herein, a sensitive and specific 
biosensor for the label-free detection of blaNDM from clinical isolates was developed. By 
implementing fluorescent microarray methods, an optimal probe was identified which 
allowed sensitive and specific target detection when transferred to the EIS platform. Use 
of PNA probes and low ionic strength conditions allowed excellent sensitivity to be 
achieved. Using a synthetic oligonucleotide complement to the selected probe, standard 
curves were established demonstrating functionality of the online EIS assay design. 
Following optimal enzymatic digestion, single stranded PCR product could be detected 
directly without the need to label the target. Specificity relative to a negative control PCR 
product was significantly enhanced by addition of formamide to the measurement buffer. 
The potential for direct PCR-free detection of plasmid DNA was shown to be feasible. In 
this report we demonstrate an online EIS assay, in continued development, for rapid 
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blaNDM detection which can be applied to targets of various levels of complexity and 
which could be implemented as a rapid, cost effectiv  test suitable for point of care use. 
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Figure 1: Fluorescence microarray data showing mean fluorescence for each probe 
developed in silico, upon hybridization of 4ng/µL fluorescently labelled blaNDM-1 PCR 
product; n=5. Excluding controls blaNDM-1 probe 7S3’ yields highest detection 
sensitivity. The nomenclature signifies probe number followed by sense (S)/ anti-sense 








Figure 2: Dose-response curve of EIS detection of sh rt synthetic oligonucleotide using 
PNA probe P7 constructed using Rct value at 60 min (52 min post sample addition) 






Figure 3: Online EIS detection assay plot showing Rct changes on P7 functionalised 
electrodes over time post addition of 10 nM PCR product treated with Lambda 
exonuclease for different incubation times (0-25 min) normalized to baseline Rct 
values. A synthetic ssDNA oligonucleotide non-complementary to the probe was 
included as a negative control (nc ssDNA), showing response comparable to that of 
dsDNA without Lambda exonuclease treatment (0 min). A 20% enhancement in EIS 
Rct increase was achieved by increasing the Lambda exonuclease incubation time from 






Figure 4: Dose response curve for 620 bp ssDNA blaNDM-1 PCR product detected with 
the online EIS assay applying  PNA probe P7 using Rct values at 60 min (52 min post 







Figure 5: Rct changes over time  upon hybridization with 10 nM ssDNA blaNDM-1 PCR 
products and non-complementary mecA PCR products (negative control) under ambient 
conditions in the presence and absence of 50% formamide in the EIS buffer normalized 
to baseline Rct values (target addition after 8 min). The figure shows the enhancement 







Figure 6: Direct detection of NDM-1 plasmid DNA. Online EIS detection assay plot 
showing Rct change on blaNDM-1 specific PNA P7 functionalised electrodes normalised 
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